Comparison of polymyxin B with other antimicrobials in the treatment of ventilator-associated pneumonia and tracheobronchitis caused by Pseudomonas aeruginosa or Acinetobacter baumannii

被引：0
作者：
M. H. Rigatto
V. B. Ribeiro
D. Konzen
A. P. Zavascki
机构：
[1] Hospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul,Infectious Diseases Service
[2] Hospital de Clínicas de Porto Alegre,Laboratory of Microbiology
[3] Pontifícia Universidade Católica do Rio Grande do Sul,School of Medicine
[4] Hospital de Clínicas de Porto Alegre,Infectious Diseases Service
来源：
Infection | 2013年 / 41卷
关键词：
Polymyxin B; Colistin; Ventilator-associated pneumonia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：321 / 328
页数：7
相关论文
共 50 条
  • [21] The role of aerosolized antimicrobials in the treatment of ventilator-associated pneumonia
    Dhand, Rajiv
    RESPIRATORY CARE, 2007, 52 (07) : 866 - 884
  • [22] Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin-Sulbactam
    Zalts, Ronen
    Neuberger, Ami
    Hussein, Khetam
    Raz-Pasteur, Ayelet
    Geffen, Yuval
    Mashiach, Tanya
    Finkelstein, Renato
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (01) : E78 - E85
  • [23] Colistin Inhalation Monotherapy for Ventilator-Associated Pneumonia of Acinetobacter baumannii in Prematurity
    Kang, Chia-Hao
    Tsai, Chih-Min
    Wu, Tin-Hsin
    Wu, Hsin-Yi
    Chung, Mei-Yung
    Chen, Chih-Cheng
    Huang, Yi-Chuan
    Liu, Shih-Feng
    Liao, Da-Ling
    Niu, Chen-Kuang
    Lee, Chen-Hsiang
    Yu, Hong-Ren
    PEDIATRIC PULMONOLOGY, 2014, 49 (04) : 381 - 388
  • [24] Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia
    Aydemir, H.
    Akduman, D.
    Piskin, N.
    Comert, F.
    Horuz, E.
    Terzi, A.
    Kokturk, F.
    Ornek, T.
    Celebi, G.
    EPIDEMIOLOGY AND INFECTION, 2013, 141 (06) : 1214 - 1222
  • [25] Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia
    Albin, Owen R.
    Kaye, Keith S.
    McCreary, Erin K.
    Pogue, Jason M.
    CLINICAL INFECTIOUS DISEASES, 2023, 76 (04) : 745 - 749
  • [26] Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii
    Schafer, Jason J.
    Goff, Debra A.
    Stevenson, Kurt B.
    Mangino, Julie E.
    PHARMACOTHERAPY, 2007, 27 (07): : 980 - 987
  • [27] Polymyxin B in Combination with Antimicrobials Lacking In Vitro Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections
    Rigatto, Maria Helena
    Vieira, Fabiane J.
    Antochevis, Laura C.
    Behle, Taina F.
    Lopes, Natane T.
    Zavascki, Alexandre P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (10) : 6575 - 6580
  • [28] Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa
    Furtado, Guilherme Henrique Campos
    d'Azevedo, Pedro Alves
    Santos, Anderson Fernandes
    Gales, Ana Cristina
    Pignatari, Antonio Carlos Campos
    Medeiros, Eduardo Alexandrino Servolo
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (04) : 315 - 319
  • [29] Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors
    Chaari, Anis
    Mnif, Basma
    Bahloul, Mabrouk
    Mahjoubi, Fouzia
    Chtara, Kamilia
    Turki, Olfa
    Gharbi, Nourhene
    Chelly, Hedi
    Hammami, Adnene
    Bouaziz, Mounir
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2013, 17 (12) : E1225 - E1228
  • [30] Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
    Tuna Demirdal
    Ummu Sena Sari
    Salih Atakan Nemli
    Annals of Clinical Microbiology and Antimicrobials, 15
12345